Skip to main content
. 2024 Aug 15;15:1427365. doi: 10.3389/fpsyt.2024.1427365

Table 2.

Summary of Mild Adverse Events. No Serious Adverse Experiences were reported, and all Adverse Events were Mild.

Mild Adverse Events Relationship to the study device
N° pat. (%) N° AE Duration (days)* Definitely Probably Possibly Unrelated
Total (n=34) 5 (14.7%) 9 10.3 (20.4) 5 2 1 1
Skin and subcutaneous tissue disorders 3 (8.8%) 4 21.7 (33.2) 3 1
Erythema 1 (2.9%) 1 4.0 ( .) 1
Paraesthesia 1 (2.9%) 2 1.0 ( .) 2
Skin burning sensation 1 (2.9%) 1 60.0 ( .) 1
Nervous system disorders 2 (5.9%) 2 1.5 ( 0.7) 1 1
Headache 2 (5.9%) 2 1.5 ( 0.7) 1 1
Infections and infestations 1 (2.9%) 1 11.0 ( .) 1
Sinusitis 1 (2.9%) 1 11.0 ( .) 1
Musculoskeletal and connective tissue disorders 1 (2.9%) 2 1.5 ( 0.7) 2
Myalgia 1 (2.9%) 2 1.5 ( 0.7) 2